母亲使用拉贝洛尔治疗对新生儿的不良影响。
Adverse neonatal effects of maternal labetalol treatment.
作者信息
Crooks B N, Deshpande S A, Hall C, Platt M P, Milligan D W
机构信息
Newcastle Neonatal Service, Royal Victoria Infirmary, Newcastle upon Tyne.
出版信息
Arch Dis Child Fetal Neonatal Ed. 1998 Sep;79(2):F150-1. doi: 10.1136/fn.79.2.f150.
Abstract
Two infants with features of severe beta adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.
摘要
两名患有严重β-肾上腺素能阻滞、心包积液和心肌肥厚症状的婴儿，其母亲在孕期因高血压接受了长期口服拉贝洛尔治疗。这些问题的病因被认为与拉贝洛尔有关。心包积液和心肌肥厚与新生儿拉贝洛尔毒性并无关联。
相似文献
1
Adverse neonatal effects of maternal labetalol treatment.母亲使用拉贝洛尔治疗对新生儿的不良影响。
Arch Dis Child Fetal Neonatal Ed. 1998 Sep;79(2):F150-1. doi: 10.1136/fn.79.2.f150.
2
Is labetalol really a culprit in neonatal hypoglycaemia?拉贝洛尔真的是新生儿低血糖的罪魁祸首吗？
Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F185. doi: 10.1136/archdischild-2012-303057. Epub 2012 Oct 31.
3
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.联合α和β受体抑制治疗高血压。
Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005.
4
Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy.在母亲使用拉贝洛尔治疗后，使用胰高血糖素治疗新生儿低输出量充血性心力衰竭。
J Pediatr. 1995 Jul;127(1):151-3. doi: 10.1016/s0022-3476(95)70277-6.
5
Current status of labetalol, the first alpha- and beta-blocking agent.拉贝洛尔（第一种α和β受体阻滞剂）的现状
Int J Clin Pharmacol Ther Toxicol. 1985 Nov;23(11):617-28.
6
Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.孕晚期β受体阻滞剂暴露与新生儿低血糖和心动过缓风险
Pediatrics. 2016 Sep;138(3). doi: 10.1542/peds.2016-0731.
7
[Treatment of arterial hypertension in pregnancy with an alpha-beta blocker. 58 Cases treated with labetalol].
Rev Fr Gynecol Obstet. 1984 Nov;79(11):713-7.
8
Effects of maternal labetalol on the newborn infant.
Indian Pediatr. 1992 Dec;29(12):1507-12.
9
Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy.
Aust N Z J Obstet Gynaecol. 1986 Feb;26(1):26-9. doi: 10.1111/j.1479-828x.1986.tb01523.x.
10
Use of labetalol in the treatment of severe hypertension during pregnancy.拉贝洛尔在妊娠期重度高血压治疗中的应用。
Br J Clin Pharmacol. 1979;8(Suppl 2):211S-215S.
引用本文的文献
1
Use of medication for cardiovascular disease during pregnancy.妊娠期心血管疾病药物治疗。
Nat Rev Cardiol. 2015 Dec;12(12):718-29. doi: 10.1038/nrcardio.2015.172.
本文引用的文献
1
Neonatal adrenergic blockade following single dose maternal labetalol administration.
Am J Perinatol. 1994 Mar;11(2):91-3. doi: 10.1055/s-2007-994563.
2
Effect of labetalol infusion on uterine and fetal hemodynamics and fetal cardiac function.
Eur J Obstet Gynecol Reprod Biol. 1993 Oct;51(2):111-7. doi: 10.1016/0028-2243(93)90022-5.
3
Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy.在母亲使用拉贝洛尔治疗后，使用胰高血糖素治疗新生儿低输出量充血性心力衰竭。
J Pediatr. 1995 Jul;127(1):151-3. doi: 10.1016/s0022-3476(95)70277-6.
4
Side effects of labetalol in newborn infants.拉贝洛尔在新生儿中的副作用。
Br J Obstet Gynaecol. 1983 Sep;90(9):876. doi: 10.1111/j.1471-0528.1983.tb09333.x.
5
The effect of maternal labetalol on the newborn infant.
Br J Obstet Gynaecol. 1986 Jun;93(6):539-42. doi: 10.1111/j.1471-0528.1986.tb07950.x.
6
Half-life of maternal labetalol in a premature infant.早产婴儿体内母亲使用的拉贝洛尔的半衰期。
Pharm Weekbl Sci. 1989 Dec 15;11(6):229-31. doi: 10.1007/BF01959416.
7
Severe adverse effects of maternal labetalol in a premature infant.母亲使用拉贝洛尔对一名早产儿产生的严重不良反应。
Acta Paediatr Scand. 1989 Nov;78(6):956-8. doi: 10.1111/j.1651-2227.1989.tb11183.x.
8
Fetal death following labetalol administration in pre-eclampsia.
Acta Obstet Gynecol Scand. 1992 Feb;71(2):145-7. doi: 10.3109/00016349209007974.
Zotero 插件